|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net increase/(decrease) in net assets resulting from operations | |
| Adjustments to reconcile net increase (decrease) in partners’ capital resulting from operations to net cash provided by (used in) operating activities: | |
| Net unrealized (appreciation)/depreciation from investments | |
| Net realized (gain)/loss from investments | |
| Accretion of original issue discount/premium on investments | |
| Amortization of deferred financing costs | |
| Purchases of investments, net of deferred fees | |
| Interest received-in kind | |
| Proceeds from the sale and paydowns of investments | |
| Change in operating assets and liabilities | |
| Increase/(Decrease) in due from affiliates | |
| (Increase)/Decrease in interest receivable and other assets | |
| Increase/(Decrease) in security deposits | |
| Increase/(Decrease) in accrued expenses and other liabilities | |
| Increase/(Decrease) in management fees payable, incentive fees payable, and interest payable | |
| Net cash provided by (used in) operating activities | |
| Cash flows from financing activities | |
| Capital contributions | |
| Capital distributions | |
| Borrowings under Credit Facility | |
| Repayments under Credit Facility | |
| Deferred credit facility costs paid | |
| Issuance of Series A Notes, net of issuance costs | |
| Net cash provided by (used in) financing activities | |
| Net increase (decrease) in cash and cash equivalents | |
| Cash and cash equivalents, beginning of period | |
| Cash and cash equivalents, end of period | |
| Supplemental disclosure of cash flow information: | |
| Cash paid during the period for interest |
Loading...
